Your browser doesn't support javascript.
loading
Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment.
de Souza, Izadora; Ramalho, Maria Carolina Clares; Guedes, Camila Banca; Osawa, Isabeli Yumi Araújo; Monteiro, Linda Karolynne Seregni; Gomes, Luciana Rodrigues; Rocha, Clarissa Ribeiro Reily.
Afiliación
  • de Souza I; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil.
  • Ramalho MCC; Laboratory of Cell Cycle, Center of Toxins, Immune Response and Cell Signaling (CeTICS), Butantan Institute, Sao Paulo 05503-001, Brazil.
  • Guedes CB; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil.
  • Osawa IYA; Laboratory of Cell Cycle, Center of Toxins, Immune Response and Cell Signaling (CeTICS), Butantan Institute, Sao Paulo 05503-001, Brazil.
  • Monteiro LKS; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil.
  • Gomes LR; Laboratory of Cell Cycle, Center of Toxins, Immune Response and Cell Signaling (CeTICS), Butantan Institute, Sao Paulo 05503-001, Brazil.
  • Rocha CRR; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04037-003, Brazil.
Int J Mol Sci ; 23(13)2022 Jun 21.
Article en En | MEDLINE | ID: mdl-35805884

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Ferroptosis / Glioma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Ferroptosis / Glioma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza